Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Vietnam flag Vietnam · Delayed Price · Currency is VND
126,500
0.00 (0.00%)
At close: Apr 24, 2026
Market Cap1.18T +3.3%
Revenue (ttm)546.57B +9.7%
Net Income60.08B +2.7%
EPS6,437.95 +2.7%
Shares Out9.33M
PE Ratio19.65
Forward PEn/a
Dividend2,400.00 (1.90%)
Ex-Dividend DateApr 21, 2026
Volume100
Average Volume891
Open126,500
Previous Close126,500
Day's Range126,500 - 126,500
52-Week Range100,200 - 189,000
Beta-0.20
RSI40.42
Earnings DateApr 24, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company manufactures and sells pharmaceutical products in Vietnam. The company offers over the counter drug products, such as medicines from medicinal herbs; minerals and vitamins; eye, ENT, and cough treatment; disinfectants; anti-allergic drugs; gastrointestinal and hepatobiliary drugs; external medications; drugs to treat parasites and bacterial infections analgesic, antipyretic, anti-inflammatory, and gout treatment; cardiovascular and diabetes; and psychoactive drugs. It is also involved in th... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 516
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PMC
Full Company Profile

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 60.08 billion, an increase of 2.71%.

Financial Statements